Skip to main content
TipRanks
Go Ultimate75% OFF

Exosens (EXENS) Stock Price & Analysis

26 Followers

EXENS Stock Chart & Stats

€50.90-€1.40(-2.68%)
At close: 5:30 PM GMT+1
€50€55€60€65Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 50.50 - EUR 51.60
52-Week Range
EUR 40.00 - EUR 74.00
Previous Close
EUR 52.30
Volume
N/A
Average Volume (3M)
83.04K
Market Cap
EUR 2.59B
Enterprise Value
EUR 3.08B
Total Cash (Recent Filing)
EUR 105.20M
Total Debt (Recent Filing)
EUR 269.50M
Price to Earnings (P/E)
86.3
Beta
0.63
Next Earnings
Feb 22, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
0.59%

Bulls Say, Bears Say

Bulls Say

Consistent Revenue Growth

Sustained revenue growth across multiple years indicates expanding demand for Exosens’ optoelectronic and imaging offerings. Continued top-line progress supports investment in product development, strengthens customer relationships, and provides a durable foundation for future earnings growth.

Improved Profitability

The transition from earlier losses to sustained profitability demonstrates meaningful operating improvement and a stronger earnings model. EBITDA margins near 30% in recent years suggest that Exosens has built substantial operating profitability that can support reinvestment and financial resilience.

Material Deleveraging

Substantial deleveraging has improved Exosens’ balance-sheet flexibility and reduced the financial burden inherited from earlier years. A larger equity base relative to debt should provide greater capacity to absorb business variability, fund strategic initiatives, and maintain operations through procurement cycles.

Bears Say

Gross-Margin Compression

The steep gross-margin decline raises concerns about the durability of Exosens’ recent profitability, whether caused by product mix, pricing pressure, or cost inflation. If the weaker margin persists, it could reduce earnings leverage, limit reinvestment capacity, and weaken the benefit of continued revenue growth.

Volatile Free-Cash-Flow Conversion

Positive cash generation is offset by inconsistent conversion from earnings into free cash flow. The 2025 deterioration suggests that reinvestment or working-capital demands can materially affect cash availability, making funding capacity less predictable even when reported profitability remains positive.

Residual Debt Burden

Although leverage has improved substantially, Exosens still carries meaningful absolute debt and a recent history of materially higher leverage. This leaves some exposure to balance-sheet pressure if earnings or cash conversion weaken, while moderate 2025 return on equity of about 9.6% limits the offsetting benefit.

Exosens News

EXENS FAQ

What was Exosens’s price range in the past 12 months?
Exosens lowest stock price was €40.00 and its highest was €74.00 in the past 12 months.
What is Exosens’s market cap?
Exosens’s market cap is €2.59B.
When is Exosens’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Exosens’s earnings last quarter?
Exosens released its earnings results on Jul 28, 2026. The company reported €0.304 earnings per share for the quarter.
Is Exosens overvalued?
According to Wall Street analysts Exosens’s price is currently Undervalued.
Does Exosens pay dividends?
Exosens pays an annual dividend of €0.3 which represents an annual dividend yield of 0.59%. See more information on Exosens dividends here
What is Exosens’s EPS estimate?
Exosens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exosens have?
Exosens has 50,936,750 shares outstanding.
What happened to Exosens’s price movement after its last earnings report?
Exosens reported an EPS of €0.304 in its last earnings report. Following the earnings report the stock price went down -6.704%.
Which hedge fund is a major shareholder of Exosens?
Currently, no hedge funds are holding shares in FR:EXENS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology